From GlobeNewswire: 2025-06-11 09:10:00

Inspira Technologies OXY B.H.N. Ltd. announced the successful integration of its FDA-cleared ART100 system into clinical workflows at leading U.S. hospitals, driving commercial interest. The system’s use has sparked interest from U.S. and international healthcare institutions and government authorities, positioning Inspira at the forefront of life-saving technologies. CEO Dagi Ben-Noon emphasized the ART100’s trust among physicians and its potential to drive commercial demand. The Company’s global rollout strategy, expanded manufacturing capacity, and negotiations with a European government authority signal continued growth and potential strategic partnerships. For more information, visit: https://inspira-technologies.com.



Read more at GlobeNewswire: Inspira’s ART100 in Use at Tier-1 U.S. Hospitals,